HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
NEWS CRUNCH
Runners' High, Happy Feet — If you're Happy, and you know it 'Clap' your Feet

6th October 2015- A group of researchers in Germany recently published findings evidencing that runner's high is not just caused by exercise-induced endorphin release. A runner's high is a subjective sense of well-being some people experience after exercising for long periods of time. For decades, it was hypothesized that runner's high is caused by exercise-induced endorphin release. Long-distance runners have always described a runner's high as a sudden pleasant feeling of euphoria, anxiolysis, sedation, and analgesia. However, running increases blood levels of both endorphin (an opioid) and anadamide (an endocannabinoid).

The paper published by Fuss and colleagues shows that endocannabinoids may play a role. Using a combination of pharmacological, molecular genetics, and behavioral studies in mice, they discovered that wheel running increases endocannabinoids and reduces both anxiety and sensation of pain in mice. With the conclusion that for the first time, cannabinoid receptors are crucial for main aspects of a runner's high and not just exercise-induced endorphin release as perceived before. Sedation, in contrast, was not influenced by cannabinoid receptors and euphoria cannot be studied in mouse models.

About

Johannes Fuss et. al. A runner's high depends on cannabinoid receptors in mice. https://www.pnas.org/cgi/doi/10.1073/pnas.1514996112

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy